Treatment.com AI (CSE: TRUE)'s newly hired CEO Essam Hamza previously founded CloudMD and as CEO from 2019 through 2022 increased its revenue from $4 million up to over $100 million. Between December 2019 and October 2020, CloudMD gained by 1,147.27% in 10 months from $0.275 per share up to a high of $3.43 per share and traded 68.437 million shares of volume in the month it hit its high.
TRUE and Healwell AI (TSX: AIDX) are the only two publicly traded healthcare AI companies and we all know that AIDX gained by over 100% within six weeks of our recent suggestion.
TRUE's AI engine known as the Global Library of Medicine has been under development for many years, but the stock was totally undiscovered and never traded any volume prior to its new CEO joining the company in October. For example, here is a January 2022 press release about them entering into an agreement with the University of Minnesota to add more than 220 dermatologic diseases to their AI engine: click here to see.
Last week, TRUE added two new solutions to its Medical Education Suite: 1) AI Patient and 2) AI Doctor in a Pocket: click here to see.
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA has received compensation from AIDX of US$50,000 cash for a six-month marketing contract. NIA has received compensation from TRUE of US$50,000 cash for a six-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.
Preparing Americans for Hyperinflation
